Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Buprenorphine for Chronic Pain in Patients at Risk for Drug Abuse

NCT00612287 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00612287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00612287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Buprenorphine for Chronic Pain in Patients at Risk for Drug Abuse
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2009
Completion date
August 31, 2009
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain